Byetta and Maxalt drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Byetta (exenatide synthetic) and Maxalt (rizatriptan benzoate). Common drug interactions include verbigeration among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Byetta and Maxalt. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Byetta?

Byetta has active ingredients of exenatide synthetic. It is often used in diabetes. eHealthMe is studying from 60,818 Byetta users. Check the latest studies of Byetta.

What is Maxalt?

Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 12,754 Maxalt users. Check the latest studies of Maxalt.

On Jul, 14, 2026

18 people who take Byetta and Maxalt together, and have interactions are studied.

What are the common drug interactions of Byetta and Maxalt, by gender? *:

female:

Verbigeration (obsessive repetition of meaningless words and phrases)
Weight decreased
Pancreatitis (inflammation of pancreas)
Blood glucose increased
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Papillary thyroid cancer
Blood triglycerides increased
Hepatic steatosis (fatty liver disease)
Diarrhoea
Nausea (feeling of having an urge to vomit)

male:

Headache (pain in head)
Accelerated hypertension (significant hypertension)
Fall
Hallucination (an experience involving the perception of something not present)
Hypertension (high blood pressure)
Memory impairment
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
Psychomotor retardation (motor mental retardation)
Somnolence (a state of near-sleep, a strong desire for sleep)
Tibia fracture (fracture of lower leg bone)

What are the common drug interactions of Byetta and Maxalt, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Papillary thyroid cancer
Chronic kidney disease
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)

40-49:

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Papillary thyroid cancer

50-59:

Blood creatinine increased
Blood potassium decreased
Blood sodium decreased
Blood urea increased
Injection site reaction
Asthma
Blood cholesterol increased
Blood triglycerides increased
Fall
Hepatic steatosis (fatty liver disease)

60+:

Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
Metastases to lymph nodes (cancer spreads to lymph node)
Pancreatic carcinoma (pancreatic cancer)

What are the existing conditions these people have? *

Type 2 Diabetes: 12 people, 66.67%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 16.67%
Headache (pain in head): 3 people, 16.67%
Depression: 2 people, 11.11%
High Blood Cholesterol: 2 people, 11.11%
High Blood Pressure: 2 people, 11.11%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 11.11%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 2 people, 11.11%
Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 1 person, 5.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Byetta and Maxalt?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously